Rare diseases
Investigational molecules
Locations
Back to Croatia85 clinical trials in Osijek, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
CroatiaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
CroatiaZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
CroatiaLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
CroatiaBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
CroatiaA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
CroatiaA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
CroatiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
CroatiaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
CroatiaStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
CroatiaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
CroatiaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for psoriatic arthritis, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new therapeutic approaches targeting specific immune pathways.
Investigations include both biologic and non-biologic treatment options for patients with varying disease severity.
Comprehensive studies examining treatments for Crohn's Disease and Ulcerative Colitis. Research focuses on novel therapeutic compounds and combination treatments.
Trials aim to improve clinical outcomes and quality of life for patients with moderate to severe disease.
Advanced research into Multiple Sclerosis and tardive dyskinesia treatments. Studies evaluate new therapeutic approaches and compare treatment efficacy.
Focus on developing treatments that can slow disease progression and improve symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
